Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Frontiers of Cancer Care in Asia-Pacific Region: Cancer Care in Australia

Koh, E.S., and Do, V.T., and Barton, M.B., (2008) Frontiers of Cancer Care in Asia-Pacific Region: Cancer Care in Australia. Biomedical Imaging and Intervention Journal, 4 (3).

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
287Kb

Official URL: http://www.biij.org/2008/3/e30/e30.pdf

Affiliations

Liverpool Hospital, New South wales, Australia, Collaboration for Cancer Outcomes Research and Evaluation University of New South Wales
Westmead hospital, New South Wales, Australia, Dept. of Radiation Oncology

Abstract

Cancer has a significant impact on the Australian community. One in three men and one in four women will develop cancer by the age of 75. The estimated annual health expenditure due to cancer in 2000-1 in Australia was $2.7 billion, representing 5.5% of the country’s total healthcare expenditure. An historical overview of the national cancer control strategies in Australia is provided. In males, the five most common cancers in order of decreasing incidence are: prostate cancer, colorectal cancer, lung cancer, melanoma and lymphoma, while for Australian women, breast cancer is the most common cancer. Key epidemiologic information about these common cancers, current management issues and comprehensive national clinical practice guidelines (where available) are highlighted. Aspects of skin cancer, a particularly common cancer in the Australian environment – with a focus on melanoma – are also included. Cancer outcomes in Australia, measured by selected outcomes, are among the best in the world. However, there is still evidence of health inequalities, especially among patients residing in regional and remote areas, the indigenous population and people from lower socio-economic classes. Limitations of current cancer care practices in Australia, including provision of oncology services, resources and other access issues, as well as suggested improvements for future cancer care, are summarised. Ongoing implementation of national and state cancer control plans and evaluation of their effectiveness will be needed to pursue the goal of optimal cancer care in Australia. [math mode missing closing $]

Item Type:Journal
Keywords:Cancer Care Australia, Health Inequalities and Cancer Outcomes
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:4611

1. Australian Institute of Health and Welfare (AIHW). Australian Cancer Incidence and Mortality Books [Online]. 2004; Available at http://www.aihw.gov.au/cancer/data/acim_books/index.cfm. (Accessed 26 February 2008).

2. The Cancer Council Australia, The National Cancer Control Initiative, Clinical Oncological Society of Australia. Optimising Cancer Care. Melbourne: National Cancer Control Initiative, 2003.

3. Ferlay J, Bray F, Pisani P et al. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC Press, 2004.

4. Australian Institute of Health and Welfare. Australian's Health 2004. Canberra: 2006.

5. Medicare Australia. The Australian Government 2008 [Online]. Available at http://www.medicareaustralia.gov.au/public/register/index.shtml. (Accessed 15 March 2008).

6. Department of Health and Ageing. Schedule of Pharmaceutical Benefits. Canberra: National Capital Printing, 2006.

7. Commonwealth Department of Human Services and Health. Better health outcomes for Australians. National goals, targets and strategies for better health outcomes into the next century. Canberra: 1994.

8. MacLennan R. Vol. 1. Australia Cancer Society, 1987.

9. Australian Cancer Society. National Cancer Prevention Policy 1993. Woolloomooloo NSW: 1993.

10. The Cancer Council Australia. National Cancer Prevention Policy 2001-3. Melbourne: 2001.

11. National Cancer Control Initiative. Cancer control towards 2002 - the first stage of a nationally coordinated plan for cancer control. Canberra, 1998; Volume 2428.

12. National Health Priority Action Council (NHPAC). National Service Improvement Framework for Cancer. Canberra: 2005.

13. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001; 63(1-3):8-18.

14. Marks R. Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now? Australas J Dermatol 1999; 40(1):1-5.

15. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet 2005; 365(9460):687-701.

16. Gilchrest BA, Eller MS, Geller AC et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340(17):1341-8.

17. Houghton AN, Coit DG, Daud A et al. Melanoma. J Natl Compr Canc Netw 2006; 4(7):666-84.

18. NH & MRC. Clinical Practice Guidelines: The Management of Cutaneous Melanoma. Canberra: 1999.

19. The National Cancer Control Initiative. The 2002 national melanoma skin cancer survey. Melbourne: The National Cancer Control Initiative, 2003.

20. Thompson JF, Shaw HM, Stretch JR et al. The Sydney Melanoma Unit--a multidisciplinary melanoma treatment center. Surg Clin North Am 2003; 83(2):431-51.

21. Thompson JF, Uren RF. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol 2005; 6(11):877-85.

22. Thompson JF, Scolyer RA, Uren RF. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am 2006; 15(2):301-18.

23. Thompson JF, Shaw HM. Sentinel node mapping for melanoma: results of trials and current applications. Surg Oncol Clin N Am 2007; 16(1):35-54.

24. Elliott B, Scolyer RA, Suciu S et al. Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. Clin Cancer Res 2007; 13(13):3825-30.

25. NH & MRC. Clinical Practice Guidelines for the prevention, diagnosis and management of lung cancer. Sydney: The Cancer Council Australia, 2004.

26. Conron M, Phuah S, Steinfort D et al. Analysis of multidisciplinary lung cancer practice. Intern Med J 2007; 37(1):18-25.

27. Vinod SK, Hui AC, Esmaili N et al. Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia. Intern Med J 2004; 34(12):677-83.

28. Holloway L. Current practice when treating lung cancer in Australasia. Australas Radiol 2007; 51(1):62-7.

29. Commonwealth of Australia. National Drug Strategy [Online]. Available at http://www.nationaldrugstrategy.gov.au.

30. Australian Government Department of Health and Aged Care and the Ministerial Council on Drug Strategy (MCDS). National Tobacco Strategy 2004-2009. Canberra: Australian Government, Department of Health and Aged Care, 2005.

31. World Health Organization. WHO Framework Convention on Tobacco Control (WHO FCTC) [Online]. Available at http://www.whoint/tobacco/framework/en/.

32. Department of Health and Ageing. National Bowel Screening Program. 2007.

33. NH & MRC. Guidelines for the prevention, early detection and management of colorectal cancer: A guide for general practitioners. 2000.

34. NH & MRC. Guidelines for the prevention, early detection and management of colorectal cancer. 2005.

35. Young JM, Leong DC, Armstrong K et al. Concordance with national guidelines for colorectal cancer care in New South Wales: a population-based patterns of care study. Med J Aust 2007; 186(6):292-5.

36. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002. 2008; CD002200.

37. National Breast and Ovarian Cancer Centre. NBOCC Breast Health statistics, 2002 [Online]. 2008; Available at http://www.breasthealth.com/statisticsreseearch. (Accessed 15 March 2008).

38. National Breast and Ovarian Cancer Centre N&M. Clinical Practice Guidelines for the Management of Early Breast Cancer. 2nd edition. Canberra: 2001.

39. National Breast and Ovarian Cancer Centre (NBOCC). Multidisciplinary Care [Online]. 2008; Available at http://www.nbocc.org.au/. (Accessed 2 March 2008).

40. BreastScreen Australia Program. Australian Government Department of Health and Ageing [Online]. 2008; Available at http://www.breastscreen.info.au/internet/screening/publishing.nsf/Content/breastscreen-1lp. (Accessed 15 March 2008).

41. Australian Institute of Health and Welfare, National Breast Cancer Centre. Breast Cancer in Australia, an Overview, 2006. Canberra: AIHW; CAN29. (Cancer series; 34).

42. National Health & Medical Research Council. Guidelines for the Prevention, Early Detection and Management of Prostate Cancer. 2002.

43. American Urological Association. Guideline for the Management of Clinically Localised Prostate cancer - 2007 update. 2007.

44. Tannock IF, de Wit R, Berry WR et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351(15):1502-12.

45. Baade PD, Fritschi L, Aitken JF. Geographical differentials in cancer incidence and survival in Queensland: 1996-2002. Brisbane: 2005.

46. Condon J. Cancer, health services and Indigeneous Australians. Aboriginal and Torres Strait Islander Primary Health Care Review. Canberra: Office for Aboriginal and Torres Strait Islander Health, 2004; Consultant Report no.5.

47. Roder D. Comparative cancer incidence, mortality and survival in Indigenous and non-Indigenous residents of South Australia and the Northern Territory. Cancer Forum 2005; 29(1):7-9.

48. South Australian Cancer Registry. Epidemiology of cancer in South Australia. Adelaide: South Australian Cancer Registry, 1997.

49. Valery PC, Coory M, Stirling J et al. Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. Lancet 2006; 367(9525):1842-8.

50. Australian Bureau of Statistics. Australian social trends. Canberra, Australia: 2003.

51. Australian Institute of Health and Welfare, Australian Association of Cancer Registries. Cancer survival in Australia 1992-1997. Geographic categories and socioeconomic status. Canberra: AIHW, 2003; CAN 17. (Cancer Series; 22).

52. Jong KE, Smith DP, Yu XQ et al. Remoteness of residence and survival from cancer in New South Wales. Med J Aust 2004; 180(12):618-22.

53. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia 2001. 2004 Dec.

54. McCredie M, Bell J, Lee A et al. Differences in patterns of care of prostate cancer, New South Wales, 1991. Aust N Z J Surg 1996; 66(11):727-30.

55. Kricker A, Haskill J, Armstrong BK. Breast conservation, mastectomy and axillary surgery in New South Wales women in 1992 and 1995. Br J Cancer 2001; 85(5):668-73.

56. Armstrong K, O'Connell D, Leong D et al. The NSW Colorectal Cancer Care Survey 2000. New South Wales: The Cancer Council NSW, 2004.

57. Australian Medical Workforce Advisory Committee. The specialist medical and haematological oncology workforce in Australia. Sydney: AMWAC, 2001.

58. Access Economics, NSW Cancer Council. Cost of Cancer in NSW. Wolloomooloo: NSW Cancer Council, 2007.

59. Smith I, Procter M, Gelber RD et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 2007; 369(9555):29-36.

60. Berthold DR, Pond GR, Soban F et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol 2008; 26(2):242-5.

61. Department of Health and Ageing. Listing of Herceptin on the PBS. Canberra: 2006.

62. Department of Health and Ageing. Listing of Docetaxel on the PBS. Canberra: 2006.

63. Do V, Gebski V, Barton MB. The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol 2000; 57(2):131-6.

64. Coles CE, Burgess L, Tan LT. An audit of delays before and during radical radiotherapy for cervical cancer--effect on tumour cure probability. Clin Oncol (R Coll Radiol) 2003; 15(2):47-54.

65. Seel M, Foroudi F. Waiting for radiation therapy: does it matter? Australas Radiol 2002; 46(3):275-9.

66. Kenny L, Lehman M. Sequential audits of unacceptable delays in radiation therapy in Australia and New Zealand. Australas Radiol 2004; 48(1):29-34.

67. Delaney G, Jacob S, Featherstone C et al. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005; 104(6):1129-37.

68. Australian Government. Medicare Australia [Online]. 2008; Available at http://www.medicareaustralia.gov.au/provider/medicare/mbs.shtml. (Accessed 15 March 2008).

69. Victorian Government. Clinical excellence in cancer care - a model for safety and quality in Victorian cancer services. Melbourne: Metropolitan Health and Aged Care services, 2007.

70. Lee N, Puri DR, Blanco AI et al. Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck 2007; 29(4):387-400.

71. National Radiation Oncology Strategic Plan Steering Committee (NROPSC). National Strategic Plan for Radiation Oncology (Australia). Sydney: 2008.

72. The Collaboration for Cancer Outcomes Research and Evaluation. A Cancer Services Framework for Victoria and future directions for the Peter Maccallum Cancer Institute. Melbourne: 2003.

73. Cancer Institute NSW. NSW Cancer Plan 2004-2006. Sydney: Cancer Institute NSW, 2001.

74. Reis AJ. New surgical approach for late complications from spinal cord injury. BMC Surg 2006; 6:12.

75. Clinical Oncological Society of Australia, The Cancer Council Australia. Submission to the Productivity Commission study of Australia's health workforce. 2006: 1-22.

76. Commonwealth Department of Health and Ageing. Strengthening Cancer Care. Canberra: 2004.

77. NSW Cancer Institute. Multidisciplinary Teams [Online]. 2008; Available at http://www.cancerinstitute.org.au/cancer_inst/profes/mdt.html. (Accessed 10 March 2008).

78. Jemal A, Tiwari RC, Murray T et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54(1):8-29.

79. de Vries E, Schouten LJ, Visser O et al. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer 2003; 39(10):1439-46.

80. Cancer Research UK. Cancer Research UK Statistics: cancer statistics reports [Online]. 2008; Available at http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstats report. (Accessed 15 March 2008).

81. Threlfall T, Bramfeld K. Cancer survival in Western Australia resdients, 1982-1997. Perth: Health Department of Western Australia, 2000.

82. Supramaniam R, Smith D, Coates M et al. Survival from cancer in New South Wales in 1980 to 1995. Sydney: 1999.

83. Berrino F, Capocaccia R, Esteve J. Survival of cancer patients in Europe:the Eurocare-2 study. Lyon: IARC, 1999.

84. Baade P, Coory M, Ring I. Cancer survival in Queensland 1982-1995. Brisbane: Health Information Centre, 2000.

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.